Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 494.00
Low: 494.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

30 Apr 2020 12:41

RNS Number : 5196L
B.P. Marsh & Partners PLC
30 April 2020
 

30th April 2020 

 

 

B.P. Marsh & Partners Plc 

("B.P. Marsh", "the Company" or "the Group") 

 

Portfolio Update

 

Repayment of Loan:

B.P. Marsh (AIM: BPM), the specialist investor in early stage financial services businesses, is pleased to note the recent receipt of a £2m Loan Repayment from Nexus Underwriting Management Limited ("Nexus").

 

The Company provided Nexus with a £2m Revolving Credit Facility in April 2019 (the "Loan Facility") as part of a wider £16m fundraising exercise, alongside the global investment firm HPS Investment Partners LLC. This was undertaken in order to provide Nexus with sufficient capital to pursue its growth strategy via value accretive acquisitions.

 

The Loan Facility was drawn down in full and has now been repaid by Nexus, eight months earlier than the scheduled repayment date. The Loan Facility will remain in place until December 2020.

 

The Loan Facility is in addition to a further £4m facility that the Group provided to Nexus in July 2017, which is due for repayment by January 2024.

 

The Group holds an aggregate Nexus shareholding of 17.6%, having bought an initial shareholding of 5% in August 2014. Since the Group's initial investment, Nexus has become one of the largest independently owned Managing General Agencies in the UK insurance market, growing from approximately £50m of premium income in 2014 to a budgeted £345m of premium income in 2020. This premium income is generated across various specialty areas including Financial Lines, Reinsurance, Trade Credit, Marine and Aviation insurance.

 

When the Group made its first investment in Nexus, it was operating one London office. Nexus now has offices in 9 countries across Europe, America and Asia.

 

In addition, on 9th  March 2020 Nexus announced that its independent broking arm, Xenia Broking Group Limited ("Xenia"), completed the acquisition of the trade credit business of Howden UK Group Limited ("Howden"), part of Hyperion Insurance Group Ltd. Xenia will integrate Howden's trade credit business with its existing trade credit broking operations, making it one of the largest independent trade credit insurance brokers in the UK.

 

Chief Investment Officer, Daniel Topping, commented on the repayment: "Given the unprecedented challenges currently faced by the UK and Global economies, it is testament to the strength of Nexus, its management and entire team that it is able, not only to continue to pursue its growth strategy via the acquisition of Howden's trade credit business, but also that it is able to access funding on commercially favourable terms.

 

"Nexus is not immune to the impact of Covid-19, but the Group has been pleased by the response of everyone at Nexus to adapt to these challenges and work towards solidifying the long-term strength of Nexus. At B.P. Marsh we have been pleased to see this approach replicated throughout our portfolio. Whilst it is currently difficult to provide long-term impact forecasts, we believe the approach taken by our portfolio's management teams has been sensible and proportionate, and underpins our long-term partnership-led approach to investment."

 

Covid-19:

B.P. Marsh continues to monitor closely the ongoing impact of the current Covid-19 pandemic. Whilst it is too early to predict with any accuracy the long-term impact, the Group's management team is working closely with each portfolio company and its management to ensure that each of them is well positioned to mitigate the short term impact of this situation.

 

At this juncture, the Group believes each portfolio company is adequately resourced to weather the challenges currently presented by Covid-19. The Group is focussed on cash flow and considers that it has sufficient resources available, including the £2m loan repayment from Nexus, together with access to a £3m loan facility, to support investee companies if necessary. 

 

We continue to operate effectively, with all management and employees working remotely. This shift in our working arrangements has not presented any significant challenges, as the team was already in the habit of liaising with portfolio companies across multiple locations and time zones. Our portfolio companies have also implemented remote working arrangements and have demonstrated that earlier investment into systems and business continuity plans have enabled these arrangements to be implemented with minimal impact.

 

Annual Results:

B.P. Marsh anticipates that it will publish its Annual Results on 9th June 2020 as previously announced. The Group will provide a further update on the impact of Covid-19 within the Annual Results. 

 

For further information, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Sinead O'Haire

 

+44 (0)20 7233 3112

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh Pemberton / Ailsa MacMaster

 

+44 (0)20 78862500

Tavistock

Jos Simson / Simon Hudson / Tim Pearson

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

Notes to Editors: 

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk. 

 

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years. 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUBBGDSCXXDGGG
Date   Source Headline
15th Apr 201910:21 amRNSForm 8.3 - B.P Marsh & Partners PLC
4th Apr 20195:49 pmRNSDirector/PDMR Shareholding
4th Apr 20195:47 pmRNSDirector/PDMR Shareholding
4th Apr 20195:43 pmRNSDirector/PDMR Shareholding
1st Apr 20196:25 pmRNSDirector/PDMR Shareholding
1st Apr 20194:44 pmRNSInvestee Co. Update - Nexus Underwriting Mgt Ltd
20th Mar 20199:53 amRNSTransaction in Own Shares
19th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20194:41 pmRNSTransaction in Own Shares
13th Mar 20193:55 pmRNSTransaction in Own Shares
12th Mar 20192:34 pmRNSShare Buy-Back Policy Update
11th Mar 20194:54 pmRNSTransaction in Own Shares
7th Mar 20195:53 pmRNSTransaction in Own Shares
6th Mar 20195:22 pmRNSTransaction in Own Shares
5th Mar 20196:10 pmRNSDirector/PDMR Shareholding
5th Mar 20196:07 pmRNSTransaction in Own Shares
28th Feb 20195:50 pmRNSDirector/PDMR Shareholding
26th Feb 20194:51 pmRNSDirector/PDMR Shareholding
25th Feb 20196:26 pmRNSTransaction in Own Shares
21st Feb 20193:47 pmRNSTransaction in Own Shares
19th Feb 20191:09 pmRNSDirector/PDMR Shareholding
18th Feb 20194:28 pmRNSTransaction in Own Shares
8th Feb 20193:11 pmRNSDirector/PDMR Shareholding
7th Feb 20197:00 amRNSTrading Update
4th Feb 20193:45 pmRNSDirector/PDMR Shareholding
22nd Jan 20193:30 pmRNSTransaction in Own Shares
18th Jan 201911:49 amRNSInvestee Company Update - XPT Group LLC
17th Jan 20191:31 pmRNSTransaction in Own Shares
17th Jan 20191:26 pmRNSDirector/PDMR Shareholding
21st Dec 20188:22 amRNSInvestee Company Update
20th Dec 20184:39 pmRNSHolding(s) in Company
19th Dec 201812:19 pmRNSDirectorate Change
11th Dec 20185:19 pmRNSDirector/PDMR Shareholding
10th Dec 20183:46 pmRNSDirector/PDMR Shareholding
10th Dec 20183:46 pmRNSInvestee Company Update
7th Dec 20185:49 pmRNSDirector/PDMR Shareholding
6th Dec 20184:15 pmRNSTransaction in Own Shares
3rd Dec 20185:20 pmRNSTransaction in Own Shares
28th Nov 201810:53 amRNSTransaction in Own Shares
22nd Nov 20181:59 pmRNSTransaction in Own Shares
30th Oct 201811:51 amRNSInvestee Company update
29th Oct 20184:32 pmRNSDirector/PDMR Shareholding
29th Oct 201812:02 pmRNSTransaction in Own Shares
25th Oct 20186:01 pmRNSTransaction in Own Shares
23rd Oct 20186:10 pmRNSTransaction in Own Shares
18th Oct 20184:59 pmRNSDirector/PDMR Shareholding
16th Oct 20185:58 pmRNSDirector/PDMR Shareholding
16th Oct 20187:00 amRNSInterim Results
11th Oct 20187:00 amRNSShare Buy-Back Policy
12th Sep 20181:04 pmRNSInvestee Company Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.